International Society of Organoid Research (ISoOR) proudly announces the publication of Volume 2, Number 1 of its esteemed journal, Journal of Organoid & Bioscience.
From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference in Singapore last year.
The International Society of Organoid Research (ISoOR) recently marked a significant advancement in the organoid field with the introduction of its new publication: Journal of Organoid & Bioscience (JOBs).
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
From August 7 to 8, 2023, the International Society of Organoid Research (ISoOR) held its inaugural annual meeting in Singapore. Hosted by ISoOR and co-organized by the Pharmacological Society (Singapore) and Scipolis, the conference was themed "Organoid: Accelerate Your Research."
The use of organoids in preclinical research has reached a tipping point, with U.S. FDA approval of the first drug to enter clinical trials on the basis of efficacy data derived only from these advanced cell models.